1. Home
  2. NATL vs NVAX Comparison

NATL vs NVAX Comparison

Compare NATL & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NCR Atleos Corporation

NATL

NCR Atleos Corporation

HOLD

Current Price

$37.21

Market Cap

2.9B

Sector

N/A

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$7.16

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NATL
NVAX
Founded
2023
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
1.1B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
NATL
NVAX
Price
$37.21
$7.16
Analyst Decision
Buy
Hold
Analyst Count
4
8
Target Price
$42.75
$9.75
AVG Volume (30 Days)
391.4K
3.2M
Earning Date
11-05-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.74
2.07
Revenue
$4,322,000,000.00
$1,064,651,000.00
Revenue This Year
$2.83
$58.91
Revenue Next Year
$3.96
N/A
P/E Ratio
$21.39
$3.44
Revenue Growth
0.63
20.27
52 Week Low
$22.30
$5.01
52 Week High
$42.23
$11.55

Technical Indicators

Market Signals
Indicator
NATL
NVAX
Relative Strength Index (RSI) 43.10 58.83
Support Level $38.41 $6.60
Resistance Level $39.22 $7.00
Average True Range (ATR) 0.78 0.21
MACD -0.15 0.07
Stochastic Oscillator 20.77 98.20

Price Performance

Historical Comparison
NATL
NVAX

About NATL NCR Atleos Corporation

NCR Atleos Corp is financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. Atleos manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications abd Technology.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: